4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-223961
Chief Financial Officer sold 1,448 shares at $18.36 ($26,585)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lucera Erick · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-13 | Sale : show line 1 in the form 10b5-1 | −1,448 | $18.36 | $26,585 | 123,925 | D |
| Open-market sales · 1,448 sh · avg $18.36 · $26,585 | ||||||
Loading xslF345X06/ownership.xml…